A detailed history of General Partner, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, General Partner, Inc. holds 600 shares of LLY stock, worth $476,484. This represents 0.33% of its overall portfolio holdings.

Number of Shares
600
Previous 600 -0.0%
Holding current value
$476,484
Previous $543 Million 2.15%
% of portfolio
0.33%
Previous 0.35%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 01, 2024

BUY
$592.2 - $792.28 $355,320 - $475,368
600 New
600 $467 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $755B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track General Partner, Inc. Portfolio

Follow General Partner, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of General Partner, Inc., based on Form 13F filings with the SEC.

News

Stay updated on General Partner, Inc. with notifications on news.